世界の微生物叢治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Microbiome Therapies Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5252
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、微生物叢治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バクテリア、真菌、ウイルス、その他）、用途別市場規模（試験所、研究所、園芸、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・微生物叢治療の市場動向
・企業の競争状況、市場シェア
・微生物叢治療の種類別市場規模と予測2016-2027（バクテリア、真菌、ウイルス、その他）
・微生物叢治療の用途別市場規模と予測2016-2027（試験所、研究所、園芸、その他）
・微生物叢治療の北米市場規模2016-2027（アメリカ、カナダ）
・微生物叢治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・微生物叢治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・微生物叢治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・微生物叢治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（uBiome、Evolve BioSystems、Indigo Agriculture、Pivot Bio、Concentric Ag、Epibiome、CosmosID、Human Longevity、Ajinomoto Cambrooke、AnimalBiome）
・結論

Microbiome is a collective genome of microorganisms that reside inside and outside of the body, ranging from pathogenic to beneficial.

Market Analysis and Insights: Global Microbiome Therapies Market
The global Microbiome Therapies market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Microbiome Therapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Microbiome Therapies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Microbiome Therapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Microbiome Therapies market.

Global Microbiome Therapies Scope and Market Size
Microbiome Therapies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Microbiome Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Bacteria
Fungi
Virus
Others

Segment by Application
Testing Centres
Research Labs
Horticulture
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
uBiome
Evolve BioSystems
Indigo Agriculture
Pivot Bio
Concentric Ag
Epibiome
CosmosID
Human Longevity
Ajinomoto Cambrooke
AnimalBiome

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microbiome Therapies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bacteria
1.2.3 Fungi
1.2.4 Virus
1.2.5 Others
1.3 Market by Application
1.3.1 Global Microbiome Therapies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Testing Centres
1.3.3 Research Labs
1.3.4 Horticulture
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Microbiome Therapies Market Perspective (2016-2027)
2.2 Microbiome Therapies Growth Trends by Regions
2.2.1 Microbiome Therapies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Microbiome Therapies Historic Market Share by Regions (2016-2021)
2.2.3 Microbiome Therapies Forecasted Market Size by Regions (2022-2027)
2.3 Microbiome Therapies Industry Dynamic
2.3.1 Microbiome Therapies Market Trends
2.3.2 Microbiome Therapies Market Drivers
2.3.3 Microbiome Therapies Market Challenges
2.3.4 Microbiome Therapies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Microbiome Therapies Players by Revenue
3.1.1 Global Top Microbiome Therapies Players by Revenue (2016-2021)
3.1.2 Global Microbiome Therapies Revenue Market Share by Players (2016-2021)
3.2 Global Microbiome Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Microbiome Therapies Revenue
3.4 Global Microbiome Therapies Market Concentration Ratio
3.4.1 Global Microbiome Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microbiome Therapies Revenue in 2020
3.5 Microbiome Therapies Key Players Head office and Area Served
3.6 Key Players Microbiome Therapies Product Solution and Service
3.7 Date of Enter into Microbiome Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Microbiome Therapies Breakdown Data by Type
4.1 Global Microbiome Therapies Historic Market Size by Type (2016-2021)
4.2 Global Microbiome Therapies Forecasted Market Size by Type (2022-2027)

5 Microbiome Therapies Breakdown Data by Application
5.1 Global Microbiome Therapies Historic Market Size by Application (2016-2021)
5.2 Global Microbiome Therapies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Microbiome Therapies Market Size (2016-2027)
6.2 North America Microbiome Therapies Market Size by Type
6.2.1 North America Microbiome Therapies Market Size by Type (2016-2021)
6.2.2 North America Microbiome Therapies Market Size by Type (2022-2027)
6.2.3 North America Microbiome Therapies Market Size by Type (2016-2027)
6.3 North America Microbiome Therapies Market Size by Application
6.3.1 North America Microbiome Therapies Market Size by Application (2016-2021)
6.3.2 North America Microbiome Therapies Market Size by Application (2022-2027)
6.3.3 North America Microbiome Therapies Market Size by Application (2016-2027)
6.4 North America Microbiome Therapies Market Size by Country
6.4.1 North America Microbiome Therapies Market Size by Country (2016-2021)
6.4.2 North America Microbiome Therapies Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Microbiome Therapies Market Size (2016-2027)
7.2 Europe Microbiome Therapies Market Size by Type
7.2.1 Europe Microbiome Therapies Market Size by Type (2016-2021)
7.2.2 Europe Microbiome Therapies Market Size by Type (2022-2027)
7.2.3 Europe Microbiome Therapies Market Size by Type (2016-2027)
7.3 Europe Microbiome Therapies Market Size by Application
7.3.1 Europe Microbiome Therapies Market Size by Application (2016-2021)
7.3.2 Europe Microbiome Therapies Market Size by Application (2022-2027)
7.3.3 Europe Microbiome Therapies Market Size by Application (2016-2027)
7.4 Europe Microbiome Therapies Market Size by Country
7.4.1 Europe Microbiome Therapies Market Size by Country (2016-2021)
7.4.2 Europe Microbiome Therapies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Microbiome Therapies Market Size (2016-2027)
8.2 Asia-Pacific Microbiome Therapies Market Size by Type
8.2.1 Asia-Pacific Microbiome Therapies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Microbiome Therapies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Microbiome Therapies Market Size by Type (2016-2027)
8.3 Asia-Pacific Microbiome Therapies Market Size by Application
8.3.1 Asia-Pacific Microbiome Therapies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Microbiome Therapies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Microbiome Therapies Market Size by Application (2016-2027)
8.4 Asia-Pacific Microbiome Therapies Market Size by Region
8.4.1 Asia-Pacific Microbiome Therapies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Microbiome Therapies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Microbiome Therapies Market Size (2016-2027)
9.2 Latin America Microbiome Therapies Market Size by Type
9.2.1 Latin America Microbiome Therapies Market Size by Type (2016-2021)
9.2.2 Latin America Microbiome Therapies Market Size by Type (2022-2027)
9.2.3 Latin America Microbiome Therapies Market Size by Type (2016-2027)
9.3 Latin America Microbiome Therapies Market Size by Application
9.3.1 Latin America Microbiome Therapies Market Size by Application (2016-2021)
9.3.2 Latin America Microbiome Therapies Market Size by Application (2022-2027)
9.3.3 Latin America Microbiome Therapies Market Size by Application (2016-2027)
9.4 Latin America Microbiome Therapies Market Size by Country
9.4.1 Latin America Microbiome Therapies Market Size by Country (2016-2021)
9.4.2 Latin America Microbiome Therapies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Microbiome Therapies Market Size (2016-2027)
10.2 Middle East & Africa Microbiome Therapies Market Size by Type
10.2.1 Middle East & Africa Microbiome Therapies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Microbiome Therapies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Microbiome Therapies Market Size by Type (2016-2027)
10.3 Middle East & Africa Microbiome Therapies Market Size by Application
10.3.1 Middle East & Africa Microbiome Therapies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Microbiome Therapies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Microbiome Therapies Market Size by Application (2016-2027)
10.4 Middle East & Africa Microbiome Therapies Market Size by Country
10.4.1 Middle East & Africa Microbiome Therapies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Microbiome Therapies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 uBiome
11.1.1 uBiome Company Details
11.1.2 uBiome Business Overview
11.1.3 uBiome Microbiome Therapies Introduction
11.1.4 uBiome Revenue in Microbiome Therapies Business (2016-2021)
11.1.5 uBiome Recent Development
11.2 Evolve BioSystems
11.2.1 Evolve BioSystems Company Details
11.2.2 Evolve BioSystems Business Overview
11.2.3 Evolve BioSystems Microbiome Therapies Introduction
11.2.4 Evolve BioSystems Revenue in Microbiome Therapies Business (2016-2021)
11.2.5 Evolve BioSystems Recent Development
11.3 Indigo Agriculture
11.3.1 Indigo Agriculture Company Details
11.3.2 Indigo Agriculture Business Overview
11.3.3 Indigo Agriculture Microbiome Therapies Introduction
11.3.4 Indigo Agriculture Revenue in Microbiome Therapies Business (2016-2021)
11.3.5 Indigo Agriculture Recent Development
11.4 Pivot Bio
11.4.1 Pivot Bio Company Details
11.4.2 Pivot Bio Business Overview
11.4.3 Pivot Bio Microbiome Therapies Introduction
11.4.4 Pivot Bio Revenue in Microbiome Therapies Business (2016-2021)
11.4.5 Pivot Bio Recent Development
11.5 Concentric Ag
11.5.1 Concentric Ag Company Details
11.5.2 Concentric Ag Business Overview
11.5.3 Concentric Ag Microbiome Therapies Introduction
11.5.4 Concentric Ag Revenue in Microbiome Therapies Business (2016-2021)
11.5.5 Concentric Ag Recent Development
11.6 Epibiome
11.6.1 Epibiome Company Details
11.6.2 Epibiome Business Overview
11.6.3 Epibiome Microbiome Therapies Introduction
11.6.4 Epibiome Revenue in Microbiome Therapies Business (2016-2021)
11.6.5 Epibiome Recent Development
11.7 CosmosID
11.7.1 CosmosID Company Details
11.7.2 CosmosID Business Overview
11.7.3 CosmosID Microbiome Therapies Introduction
11.7.4 CosmosID Revenue in Microbiome Therapies Business (2016-2021)
11.7.5 CosmosID Recent Development
11.8 Human Longevity
11.8.1 Human Longevity Company Details
11.8.2 Human Longevity Business Overview
11.8.3 Human Longevity Microbiome Therapies Introduction
11.8.4 Human Longevity Revenue in Microbiome Therapies Business (2016-2021)
11.8.5 Human Longevity Recent Development
11.9 Ajinomoto Cambrooke
11.9.1 Ajinomoto Cambrooke Company Details
11.9.2 Ajinomoto Cambrooke Business Overview
11.9.3 Ajinomoto Cambrooke Microbiome Therapies Introduction
11.9.4 Ajinomoto Cambrooke Revenue in Microbiome Therapies Business (2016-2021)
11.9.5 Ajinomoto Cambrooke Recent Development
11.10 AnimalBiome
11.10.1 AnimalBiome Company Details
11.10.2 AnimalBiome Business Overview
11.10.3 AnimalBiome Microbiome Therapies Introduction
11.10.4 AnimalBiome Revenue in Microbiome Therapies Business (2016-2021)
11.10.5 AnimalBiome Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Microbiome Therapies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bacteria
Table 3. Key Players of Fungi
Table 4. Key Players of Virus
Table 5. Key Players of Others
Table 6. Global Microbiome Therapies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Microbiome Therapies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Microbiome Therapies Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Microbiome Therapies Market Share by Regions (2016-2021)
Table 10. Global Microbiome Therapies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Microbiome Therapies Market Share by Regions (2022-2027)
Table 12. Microbiome Therapies Market Trends
Table 13. Microbiome Therapies Market Drivers
Table 14. Microbiome Therapies Market Challenges
Table 15. Microbiome Therapies Market Restraints
Table 16. Global Microbiome Therapies Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Microbiome Therapies Market Share by Players (2016-2021)
Table 18. Global Top Microbiome Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microbiome Therapies as of 2020)
Table 19. Ranking of Global Top Microbiome Therapies Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Microbiome Therapies Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Microbiome Therapies Product Solution and Service
Table 23. Date of Enter into Microbiome Therapies Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Microbiome Therapies Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Microbiome Therapies Revenue Market Share by Type (2016-2021)
Table 27. Global Microbiome Therapies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Microbiome Therapies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Microbiome Therapies Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Microbiome Therapies Revenue Market Share by Application (2016-2021)
Table 31. Global Microbiome Therapies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Microbiome Therapies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Microbiome Therapies Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Microbiome Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Microbiome Therapies Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Microbiome Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Microbiome Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Microbiome Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Microbiome Therapies Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Microbiome Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Microbiome Therapies Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Microbiome Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Microbiome Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Microbiome Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Microbiome Therapies Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Microbiome Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Microbiome Therapies Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Microbiome Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Microbiome Therapies Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Microbiome Therapies Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Microbiome Therapies Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Microbiome Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Microbiome Therapies Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Microbiome Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Microbiome Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Microbiome Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Microbiome Therapies Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Microbiome Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Microbiome Therapies Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Microbiome Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Microbiome Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Microbiome Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 63. uBiome Company Details
Table 64. uBiome Business Overview
Table 65. uBiome Microbiome Therapies Product
Table 66. uBiome Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
Table 67. uBiome Recent Development
Table 68. Evolve BioSystems Company Details
Table 69. Evolve BioSystems Business Overview
Table 70. Evolve BioSystems Microbiome Therapies Product
Table 71. Evolve BioSystems Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
Table 72. Evolve BioSystems Recent Development
Table 73. Indigo Agriculture Company Details
Table 74. Indigo Agriculture Business Overview
Table 75. Indigo Agriculture Microbiome Therapies Product
Table 76. Indigo Agriculture Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
Table 77. Indigo Agriculture Recent Development
Table 78. Pivot Bio Company Details
Table 79. Pivot Bio Business Overview
Table 80. Pivot Bio Microbiome Therapies Product
Table 81. Pivot Bio Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
Table 82. Pivot Bio Recent Development
Table 83. Concentric Ag Company Details
Table 84. Concentric Ag Business Overview
Table 85. Concentric Ag Microbiome Therapies Product
Table 86. Concentric Ag Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
Table 87. Concentric Ag Recent Development
Table 88. Epibiome Company Details
Table 89. Epibiome Business Overview
Table 90. Epibiome Microbiome Therapies Product
Table 91. Epibiome Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
Table 92. Epibiome Recent Development
Table 93. CosmosID Company Details
Table 94. CosmosID Business Overview
Table 95. CosmosID Microbiome Therapies Product
Table 96. CosmosID Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
Table 97. CosmosID Recent Development
Table 98. Human Longevity Company Details
Table 99. Human Longevity Business Overview
Table 100. Human Longevity Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
Table 101. Human Longevity Recent Development
Table 102. Ajinomoto Cambrooke Company Details
Table 103. Ajinomoto Cambrooke Business Overview
Table 104. Ajinomoto Cambrooke Microbiome Therapies Product
Table 105. Ajinomoto Cambrooke Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
Table 106. Ajinomoto Cambrooke Recent Development
Table 107. AnimalBiome Company Details
Table 108. AnimalBiome Business Overview
Table 109. AnimalBiome Microbiome Therapies Product
Table 110. AnimalBiome Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
Table 111. AnimalBiome Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Microbiome Therapies Market Share by Type: 2020 VS 2027
Figure 2. Bacteria Features
Figure 3. Fungi Features
Figure 4. Virus Features
Figure 5. Others Features
Figure 6. Global Microbiome Therapies Market Share by Application: 2020 VS 2027
Figure 7. Testing Centres Case Studies
Figure 8. Research Labs Case Studies
Figure 9. Horticulture Case Studies
Figure 10. Others Case Studies
Figure 11. Microbiome Therapies Report Years Considered
Figure 12. Global Microbiome Therapies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Microbiome Therapies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Microbiome Therapies Market Share by Regions: 2020 VS 2027
Figure 15. Global Microbiome Therapies Market Share by Regions (2022-2027)
Figure 16. Global Microbiome Therapies Market Share by Players in 2020
Figure 17. Global Top Microbiome Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microbiome Therapies as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Microbiome Therapies Revenue in 2020
Figure 19. Global Microbiome Therapies Revenue Market Share by Type (2016-2021)
Figure 20. Global Microbiome Therapies Revenue Market Share by Type (2022-2027)
Figure 21. North America Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Microbiome Therapies Market Share by Type (2016-2027)
Figure 23. North America Microbiome Therapies Market Share by Application (2016-2027)
Figure 24. North America Microbiome Therapies Market Share by Country (2016-2027)
Figure 25. United States Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Microbiome Therapies Market Share by Type (2016-2027)
Figure 29. Europe Microbiome Therapies Market Share by Application (2016-2027)
Figure 30. Europe Microbiome Therapies Market Share by Country (2016-2027)
Figure 31. Germany Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Microbiome Therapies Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Microbiome Therapies Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Microbiome Therapies Market Share by Region (2016-2027)
Figure 41. China Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Microbiome Therapies Market Share by Type (2016-2027)
Figure 49. Latin America Microbiome Therapies Market Share by Application (2016-2027)
Figure 50. Latin America Microbiome Therapies Market Share by Country (2016-2027)
Figure 51. Mexico Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Microbiome Therapies Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Microbiome Therapies Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Microbiome Therapies Market Share by Country (2016-2027)
Figure 57. Turkey Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. uBiome Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
Figure 61. Evolve BioSystems Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
Figure 62. Indigo Agriculture Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
Figure 63. Pivot Bio Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
Figure 64. Concentric Ag Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
Figure 65. Epibiome Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
Figure 66. CosmosID Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
Figure 67. Human Longevity Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
Figure 68. Ajinomoto Cambrooke Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
Figure 69. AnimalBiome Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の直接消費者用微生物叢分析市場規模・現状・予測（2021年-2027年）

Global Direct to Consumer Microbiome Analyzing Market Size, Status and Forecast 2021-2027
QFJ1-4138 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、直接消費者用微生物叢分析の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（腸内微生物叢検査キット、健康サンプルキット、その他微生物叢検査キット）、用途別市場規模（感染症、腸の状態、代謝障害、心血管疾患、...

世界の微生物叢診断市場規模・現状・予測（2021年-2027年）

Global Microbiome Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-5251 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、微生物叢診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ゲノミクス、プロテオミクス、メタボロミクス）、用途別市場規模（感染症、内分泌・代謝性疾患、炎症性疾患、がん）、主要地域別市場規模（北米、アメ...

世界の腸内細菌叢市場規模・現状・予測（2021年-2027年）

Global Gut Microbiome Market Size, Status and Forecast 2021-2027
QFJ1-4274 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、腸内細菌叢の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肥満、炎症性腸疾患（IBD）、糖尿病、その他）、用途別市場規模（人間、動物）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のヒトマイクロバイオーム治療薬市場規模・現状・予測（2021年-2027年）

Global Human Microbiome Therapeutic Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4332 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、ヒトマイクロバイオーム治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（FMT、マイクロバイオーム医薬品、その他）、用途別市場規模（胃、口腔、気道、その他）、主要地域別市場規模（北米、アメリカ、欧...

世界の動物ミクロビオーム市場規模・現状・予測（2021年-2027年）

Global Animal Microbiome Market Size, Status and Forecast 2021-2027
QFJ1-5080 2021年6月 116Pages
QYResearch社発行の本調査レポートでは、動物ミクロビオームの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（テストサービス、補足製品）、用途別市場規模（慢性下痢、便秘、嘔吐、皮膚状態、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の皮膚用マイクロバイオームモジュレーター市場規模・現状・予測（2021年-2027年）

Global Skin Microbiome Modulator Market Size, Status and Forecast 2021-2027
QFJ1-4868 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、皮膚用マイクロバイオームモジュレーターの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（プロバイオティクス、プレバイオティクス、医薬品）、用途別市場規模（スキンケア、ヘアケア、その他）、主要地域別市場規...

世界のネオアンチゲン標的療法市場規模・現状・予測（2021年-2027年）

Global Neoantigen Targeted Therapies Market Size, Status and Forecast 2021-2027
QFJ1-5264 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、ネオアンチゲン標的療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（医療研究機関、病院・クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の睡眠時無呼吸症治療市場規模・現状・予測（2021年-2027年）

Global Sleep Apnea Therapies Market Size, Status and Forecast 2021-2027
QFJ1-4871 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、睡眠時無呼吸症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、手術、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の先進端細胞治療市場規模・現状・予測（2021年-2027年）

Global Advanced Cell Therapies Market Size, Status and Forecast 2021-2027
QFJ1-3769 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、先進端細胞治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（幹細胞移植、CART細胞療法）、用途別市場規模（幹細胞、再生医療）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...

世界の卵巣癌治療＆診断市場規模・現状・予測（2021年-2027年）

Global Therapies and Diagnostics for Ovarian Cancer Market Size, Status and Forecast 2021-2027
QFJ1-4951 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、卵巣癌治療＆診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（手術、放射線療法、薬物治療）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の直接消費者用微生物叢分析市場規模・現状・予測（2021年-2027年） Direct to Consumer Microbiome Analyzing is analyzing the microbes in consumers’ sample, then consumers can get a report on how microbiome works in their body. Market Analysis and Insights: Global Direct to Consumer Microbiome Analyzing Market The global Direct to Consumer Microbiome Analyzing market…
世界の微生物叢診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Microbiome Diagnostics Market The global Microbiome Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the repo…
世界の腸内細菌叢市場規模・現状・予測（2021年-2027年） The gut microbiome is a vast ecosystem of organisms such as bacteria, yeasts, fungi, viruses and protozoans that live in our digestive pipes, which collectively weigh up to 2kg (heavier than the average brain). The report is about Gut Microbiome Therapeutics market. Market Analysis and Insights: Glo…
世界の動物ミクロビオーム市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Animal Microbiome Market The global Animal Microbiome market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a…
世界のヒトマイクロバイオーム治療薬市場規模・現状・予測（2021年-2027年） Human microbiome therapeutic drugs are drugs made by using the relationship between the gene content of the microbiota and metabolic activities. Market Analysis and Insights: Global Human Microbiome Therapeutic Drugs Market The global Human Microbiome Therapeutic Drugs market size is projected to re…